Celon Pharma expands in Europe

Polish pharmaceutical company Celon Pharmy has signed an agreement with Indian Glenmark Pharmaceuticals Europe, Puls Biznesu daily reported. In line with the contract, the Polish firm's product will be distributed in 15 European countries for ten years. With the optional to prolong it by two more years. In addition, Celon Pharmy will receive a few million euros and eventually will share sale revenue with the Indian partner. Registration of the medicine in France (which is not included in the agreement) is ongoing, Maciej Wieczorek, the firm's founder told the daily.